1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal Trade Commission. February 4, 2026. Accessed February 5, 2026.

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy ...

WASHINGTON - Federal regulators announced a settlement Wednesday with Express Scripts to change how the company handles ...

According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...

Cost Plus Drugs founder Mark Cuban is not convinced the Federal Trade Commission’s settlement with Cigna’s Express Scripts is going to amount to very much. “My initial response to the FTC [and ...

Eli Lilly leapfrogs Novo Nordisk as sales prospects diverge sharply; FTC reaches settlement with Express Scripts over PBM’s ...

Cigna reported 11% revenue growth for 2025. Company executives focused on several key issues in its call with investors: its settlement with the Federal Trade Commission, a transformation announced ...

Resiliency and Workforce Americans are the best in the world at responding to and rebuilding from natural disaster, but we all know that we can do more to proactively plan for and prevent disasters ...

President Trump launched TrumpRx.gov, connecting Americans directly to pharmaceutical giants for massive "Most Favored Nation ...

Q4 2025 Earnings Call February 5, 2026 8:30 AM ESTCompany ParticipantsRalph Giacobbe - Senior Vice President of Investor ...

California, USA-based Coherus Oncology has entered into a clinical supply agreement with JUS healthcare giant Johnson & Johnson to evaluate tagmokitug (CHS-114).